VolitionRx Statistics
Total Valuation
VolitionRx has a market cap or net worth of $75.54 million. The enterprise value is $73.94 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VolitionRx has 92.10 million shares outstanding. The number of shares has increased by 26.18% in one year.
| Current Share Class | 92.10M |
| Shares Outstanding | 92.10M |
| Shares Change (YoY) | +26.18% |
| Shares Change (QoQ) | +6.31% |
| Owned by Insiders (%) | 7.16% |
| Owned by Institutions (%) | 9.69% |
| Float | 63.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 52.28 |
| Forward PS | 11.42 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 57.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22
| Current Ratio | 0.22 |
| Quick Ratio | 0.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -98.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -122.00% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $11,689 |
| Profits Per Employee | -$271,570 |
| Employee Count | 110 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.65% in the last 52 weeks. The beta is 1.10, so VolitionRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | +9.65% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 62.32 |
| Average Volume (20 Days) | 156,762 |
Short Selling Information
The latest short interest is 441,923, so 0.48% of the outstanding shares have been sold short.
| Short Interest | 441,923 |
| Short Previous Month | 429,740 |
| Short % of Shares Out | 0.48% |
| Short % of Float | 0.70% |
| Short Ratio (days to cover) | 3.71 |
Income Statement
In the last 12 months, VolitionRx had revenue of $1.29 million and -$29.87 million in losses. Loss per share was -$0.36.
| Revenue | 1.29M |
| Gross Profit | 1.29M |
| Operating Income | -29.98M |
| Pretax Income | -34.91M |
| Net Income | -29.87M |
| EBITDA | -28.87M |
| EBIT | -29.98M |
| Loss Per Share | -$0.36 |
Full Income StatementBalance Sheet
The company has $5.41 million in cash and $5.89 million in debt, giving a net cash position of -$472,095 or -$0.01 per share.
| Cash & Cash Equivalents | 5.41M |
| Total Debt | 5.89M |
| Net Cash | -472,095 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | -22.64M |
| Book Value Per Share | -0.24 |
| Working Capital | -23.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$14.01 million and capital expenditures -$513,620, giving a free cash flow of -$14.53 million.
| Operating Cash Flow | -14.01M |
| Capital Expenditures | -513,620 |
| Free Cash Flow | -14.53M |
| FCF Per Share | -$0.16 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -2,331.90% |
| Pretax Margin | -2,348.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -2,330.23% |